BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38362706)

  • 1. Comparison of efficacy and safety of tretinoin 0.05% and glycolic acid peeling 70% in axillary and neck lesions of acanthosis nigricans: A single-blinded, randomized trial.
    Ghiasi M; Samii R; Tootoonchi N; Balighi K; Heidari S
    J Cosmet Dermatol; 2024 Jun; 23(6):2090-2096. PubMed ID: 38362706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effectiveness of fractional 1550-nm erbium fiber laser and 0.05% tretinoin cream in the treatment of acanthosis nigricans: a prospective, randomized, controlled trial.
    Leerapongnan P; Jurairattanaporn N; Kanokrungsee S; Udompataikul M
    Lasers Med Sci; 2020 Jul; 35(5):1153-1158. PubMed ID: 31953736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of acanthosis nigricans with sequential salicylic acid-mandelic acid combination peel and maintenance with glycolic acid-urea combination cream: A retrospective pilot study.
    Zeeshan M; Arfeen N; Sonthalia S; Singh A; Roy PK
    J Cosmet Dermatol; 2022 Sep; 21(9):3905-3909. PubMed ID: 34971480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The randomized trials of 10% urea cream and 0.025% tretinoin cream in the treatment of acanthosis nigricans.
    Treesirichod A; Chaithirayanon S; Chaikul T; Chansakulporn S
    J Dermatolog Treat; 2021 Nov; 32(7):837-842. PubMed ID: 31868565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the efficacy and safety profiles of 0.025% and 0.05% tretinoin creams in treating acanthosis nigricans: a randomized double-blinded study.
    Kritsanaviparkporn C; Treesirichod A
    Arch Dermatol Res; 2023 May; 315(4):963-970. PubMed ID: 36416980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the efficacy and safety of 0.1% adapalene gel and 0.025% tretinoin cream in the treatment of childhood acanthosis nigricans.
    Treesirichod A; Chaithirayanon S; Wongjitrat N
    Pediatr Dermatol; 2019 May; 36(3):330-334. PubMed ID: 30883877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study using fractional carbon dioxide laser versus glycolic acid peel in treatment of pseudo-acanthosis nigricans.
    Zaki NS; Hilal RF; Essam RM
    Lasers Med Sci; 2018 Sep; 33(7):1485-1491. PubMed ID: 29713841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of combination of glycolic acid peeling with topical regimen in treatment of melasma.
    Chaudhary S; Dayal S
    J Drugs Dermatol; 2013 Oct; 12(10):1149-53. PubMed ID: 24085051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glycolic acid peeling on the cutaneous manifestation of generalized acanthosis nigricans caused by FGFR3 mutation: A report of one sporadic and two familial cases.
    Ichiyama S; Kubo A; Matayoshi T; Saeki H; Funasaka Y
    J Dermatol; 2017 Oct; 44(10):e250-e251. PubMed ID: 28620983
    [No Abstract]   [Full Text] [Related]  

  • 10. Tretinoin peels versus glycolic acid peels in the treatment of Melasma in dark-skinned patients.
    Khunger N; Sarkar R; Jain RK
    Dermatol Surg; 2004 May; 30(5):756-60; discussion 760. PubMed ID: 15099320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The efficacy and safety of 20% urea cream and 10% urea cream in the treatment of acanthosis nigricans in adolescents, a randomized comparative double-blind study.
    Treesirichod A; Chuenboonngarm S; Kritsanaviparkporn C
    J Cosmet Dermatol; 2022 Jul; 21(7):2859-2864. PubMed ID: 34619001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical therapy with tretinoin and ammonium lactate for acanthosis nigricans associated with obesity.
    Blobstein SH
    Cutis; 2003 Jan; 71(1):33-4. PubMed ID: 12553628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of lasers versus topical medications for acanthosis nigricans and pseudo-acanthosis nigricans treatment: a systematic review.
    Ghane Y; Heidari N; Hosseini S; Heidari A; Pishraft-Sabet H; Eghbali S; Goodarzi A
    Lasers Med Sci; 2024 Jan; 39(1):44. PubMed ID: 38253899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of topical therapy for striae alba (20% glycolic acid/0.05% tretinoin versus 20% glycolic acid/10% L-ascorbic acid).
    Ash K; Lord J; Zukowski M; McDaniel DH
    Dermatol Surg; 1998 Aug; 24(8):849-56. PubMed ID: 9723049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between 1% tretinoin peeling versus 70% glycolic acid peeling in the treatment of female patients with melasma.
    Faghihi G; Shahingohar A; Siadat AH
    J Drugs Dermatol; 2011 Dec; 10(12):1439-42. PubMed ID: 22134569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris in an Asian Population.
    Han G; Armstrong AW; Desai SR; Guenin E
    J Drugs Dermatol; 2019 Sep; 18(9):910-916. PubMed ID: 31524347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of salicylic acid peeling in comparison with topical tretinoin in the treatment of postinflammatory hyperpigmentation.
    Mohamed Ali BM; Gheida SF; El Mahdy NA; Sadek SN
    J Cosmet Dermatol; 2017 Mar; 16(1):52-60. PubMed ID: 27976510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients: efficacy and improvement in quality of life.
    Dayal S; Sahu P; Dua R
    J Cosmet Dermatol; 2017 Mar; 16(1):35-42. PubMed ID: 27500896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical efficacy and safety of 20% glycolic peel, 15% lactic peel, and topical 20% vitamin C in constitutional type of periorbital melanosis: a comparative study.
    Dayal S; Sahu P; Jain VK; Khetri S
    J Cosmet Dermatol; 2016 Dec; 15(4):367-373. PubMed ID: 27380862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective treatment by glycolic acid peeling for cutaneous manifestation of familial generalized acanthosis nigricans caused by FGFR3 mutation.
    Ichiyama S; Funasaka Y; Otsuka Y; Takayama R; Kawana S; Saeki H; Kubo A
    J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):442-5. PubMed ID: 26818779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.